Lurbinectedin is a medication used to treat small cell lung cancer that has progressed despite other treatments. The most common side effects of Lurbinectedin are myelosuppression, which is a decrease in the production of blood cells, and fatigue. Other side effects may include nausea, vomiting, constipation, diarrhea, loss of appetite, hair loss, and increased liver enzymes.

Myelosuppression can lead to a decrease in white blood cells, red blood cells, and platelets, which can increase the risk of infection, anemia, and bleeding. Patients may also experience fatigue, which can be severe. Other side effects, such as nausea, vomiting, constipation, and diarrhea, can be managed with medication and changes in diet.

Less common side effects of Lurbinectedin may include fever, chills, cough, shortness of breath, headache, dizziness, confusion, rash, and swelling of the face, lips, or tongue. Patients should seek medical attention if they experience any of these symptoms.

It is important for patients to discuss any side effects they experience with their healthcare provider, as they may be able to provide additional support and management strategies.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[3] https://www.zepzelca.com/zepzelca-side-effects/